Brief: ALX Oncology Q4 Basic EPS USD -0.93
07/03/2024 21:03
Mar 07 (Reuters) - ALX Oncology Q4 net income USD -45.472 million. * Q4 operating expenses USD 48.023 million * Q4 income from operations USD -48.023 million
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing